It is imperative the issues raised by patients and their care partners through the biennial survey, interviews, focus groups and other initiatives are conveyed to the medical and research communities to improve care moving forward.
[{"id":40059,"link":"https:\/\/lymphomacoalition.org\/patient-experience-and-doctor-communication-in-lymphoma-and-cll-clinical-trials-vs-non-clinical-trials\/","name":"patient-experience-and-doctor-communication-in-lymphoma-and-cll-clinical-trials-vs-non-clinical-trials","thumbnail":{"url":"https:\/\/lymphomacoalition.org\/wp-content\/uploads\/A-comparative-analysis-of-patient-experience-and-patient-doctor-communication-in-patients-with-lymphoma-and-CLL-Clinical-trials-versus-non-Clinical-trials.png","alt":""},"title":"Patient Experience and Doctor Communication in Lymphoma and CLL: Clinical Trials vs. non-Clinical Trials","author":{"name":"","link":"https:\/\/lymphomacoalition.org\/author\/firstname lastname\/"},"date":"Dec 12, 2021","dateGMT":"2021-12-12 18:32:00","modifiedDate":"2025-10-14 15:07:54","modifiedDateGMT":"2025-10-14 15:07:54","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/lymphomacoalition.org\/category\/treatmentsideeffects\/clinicaltrials\/\" rel=\"category tag\">Clinical Trials<\/a>, <a href=\"https:\/\/lymphomacoalition.org\/category\/commdecision-making\/\" rel=\"category tag\">Communication & Decision-Making<\/a>, <a href=\"https:\/\/lymphomacoalition.org\/category\/commdecision-making\/doctor-patientcommunication\/\" rel=\"category tag\">Doctor\u2013Patient Communication<\/a>, <a href=\"https:\/\/lymphomacoalition.org\/category\/lc-research\/\" rel=\"category tag\">LC Research<\/a>, <a href=\"https:\/\/lymphomacoalition.org\/category\/commdecision-making\/shareddecision-making\/\" rel=\"category tag\">Shared Decision-Making<\/a>, <a href=\"https:\/\/lymphomacoalition.org\/category\/treatmentsideeffects\/\" rel=\"category tag\">Treatment & Side Effects<\/a>","space":"<a href=\"https:\/\/lymphomacoalition.org\/category\/treatmentsideeffects\/clinicaltrials\/\" rel=\"category tag\">Clinical Trials<\/a> <a href=\"https:\/\/lymphomacoalition.org\/category\/commdecision-making\/\" rel=\"category tag\">Communication & Decision-Making<\/a> <a href=\"https:\/\/lymphomacoalition.org\/category\/commdecision-making\/doctor-patientcommunication\/\" rel=\"category tag\">Doctor\u2013Patient Communication<\/a> <a href=\"https:\/\/lymphomacoalition.org\/category\/lc-research\/\" rel=\"category tag\">LC Research<\/a> <a href=\"https:\/\/lymphomacoalition.org\/category\/commdecision-making\/shareddecision-making\/\" rel=\"category tag\">Shared Decision-Making<\/a> <a href=\"https:\/\/lymphomacoalition.org\/category\/treatmentsideeffects\/\" rel=\"category tag\">Treatment & Side Effects<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":5,"sec":4},"status":"publish","excerpt":"Presented at the 63d American Society of Hematology (ASH) conference on 12 December. Clinical trials are essential in ensuring that new treatments are safe and effective and are also a way to improve standards of care. Patients enrolled in clinical trials receive optimal clinical care due to the close management included in trial design.\n\nUsing the 2020 Lymphoma Coalition (LC) Global Patient Survey (GPS) on lymphomas and CLL, this study aims to provide insight into the experience of patients with lymphoma and CLL who have participated in a clinical trial compared to those who have not."}]